Facts
as of Nov 17, 2026
Earli is a biotechnology company developing a BioAI approach to cancer therapy in which drugs are produced only in the tumor, by the tumor. Its aim is to avoid systemic toxicity and enable localized immune activation, and it hires scientists in bio AI and in vivo pharmacology. The company is headquartered in Redwood City, United States.
It is hiring: 2 open roles, 0 of them posted in the last 30 days.
- Headquarters
- Redwood City, United States
- Employees
- 11-50estimated range
- Open roles
- 2Alion job postings
- Website
- earli.com
As of Nov 17, 2026, Alion lists 2 open roles at Earli. Earli is headquartered in Redwood City, United States. It has raised $145M in 2 funding rounds. The latest round is Venture - Series Unknown of $105M, announced in 2026.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring slowly: few roles were posted lately.
Biotech is the largest family, 100 of open roles.
0%Remote roles0 of 2
1Roles in AI50% of open roles
1Hiring offices
Can they hire you from United States?by your location
Likely
2 open roles are in your country: you apply locally, no move needed.
United States2On site
Remote, from elsewhere0Rare
No posting offers visa sponsorship. Remote roles: 0.
Alion signals0-100
Demand22
Pay35
Your chance47
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 21This week
Open roles a week: 2 then, 0 now
Where the openings areshare of open roles · trend
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Pay
What its postings pay, by level.
$235kMedian
$235kTypical rangeUSD a year
$235kHighest paying roleSenior Scientist, Bio AI
Source: the pay stated in the company's postings, normalised to USD a year
Named in the work visa registers of United States.
3 ▲ 50%H-1B filings in 12 months
$143kMedian offered salary
2Open roles in United States
In the register as Earli Inc., Redwood City, CA
Other sponsors in the same field
US Department of Labor · latest filing May 22, 2026
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
Redwood CityBusiest site
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$145MTotal raised
Venture - Series UnknownLatest round
2Rounds and grants
Money by yearUSD, rounds and grants
2026$105M1 record
2021$40M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers
Tech stack
Technologies named in job postings at Earli over the last 12 months, by layer, with the share of postings for each.
8Technologies in use
2Postings analysed
66/100Stack modernity
Frameworks & librariesShiny
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Milestones
Each milestone is dated by its source: registers, filings, the press
Newsroom
Mar 172026
News · BiotechTV
Co-Founder & CEO Cyriac Roeding and Co-Founder & CSO David Suhy describe the science behind this approach and explain how AI is helping they move closer to the clinic. The first…
Dec 19, 20242024
News · Entrepreneur
What happens when a Silicon Valley entrepreneur, a synthetic biology expert, and a world-renowned cancer researcher team up? They create Earli-a startup rewriting the rules of ca…
Aug 20, 20242024
News · Pharmaceutical Technology
Accenture has made an investment in biotechnology company Earli for advancing early cancer detection technologies.
Aug 19, 20242024
Press release · businesswire
Accenture has made a strategic investment, through Accenture Ventures, in Earli Inc., a biotechnology company.
Sources: the outlets named on each headline, each story once